Altshuler Shaham’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-455
Closed -$26.4K 264
2023
Q3
$26.4K Sell
455
-105
-19% -$6.43K ﹤0.01% 184
2023
Q2
$35.8K Sell
560
-57
-9% -$3.82K ﹤0.01% 204
2023
Q1
$42.8K Sell
617
-787
-56% -$55.5K ﹤0.01% 208
2022
Q4
$101K Sell
1,404
-2,034
-59% -$153K ﹤0.01% 159
2022
Q3
$247K Sell
3,438
-126
-4% -$9.14K 0.01% 119
2022
Q2
$274K Buy
3,564
+1,370
+62% +$104K ﹤0.01% 119
2022
Q1
$161K Buy
2,194
+1,094
+99% +$73.5K ﹤0.01% 237
2021
Q4
$69K Buy
1,100
+335
+44% +$19.7K ﹤0.01% 361
2021
Q3
$46K Buy
+765
New +$50.4K ﹤0.01% 430
2021
Q2
Sell
-1,985
Closed -$126K 620
2021
Q1
$126K Buy
1,985
+213
+12% +$13.3K ﹤0.01% 199
2020
Q4
$110K Sell
1,772
-515
-23% -$31.7K ﹤0.01% 188
2020
Q3
$138K Sell
2,287
-617
-21% -$37.1K ﹤0.01% 148
2020
Q2
$171K Sell
2,904
-6,017
-67% -$360K 0.01% 129
2020
Q1
$497K Buy
8,921
+8,227
+1,185% +$503K 0.02% 87
2019
Q4
$45K Sell
694
-23,075
-97% -$1.32M ﹤0.01% 192
2019
Q3
$1.19M Sell
23,769
-4,891
-17% -$230K 0.05% 65
2019
Q2
$1.3M Buy
+28,660
New +$1.33M 0.05% 71

Other funds holding BMY

Altshuler Shaham's BMY Position: Q4 2023 in Review

Altshuler Shaham sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 455 shares — an estimated $26.4K sold.

Altshuler Shaham first reported a position in BMY in Q2 2019 and held it in 17 quarters. The position peaked at $1.3M in Q2 2019. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Altshuler Shaham reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Altshuler Shaham sold 455 Bristol-Myers Squibb shares in Q4 2023, an estimated $26.4K.
  • Altshuler Shaham first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 17 quarters.
  • Altshuler Shaham's Bristol-Myers Squibb position peaked at $1.3M in Q2 2019.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Altshuler Shaham's 13F filing for Q4 2023, filed 7 Feb 2024.